Amsterdam Reproduction & Development
-
Atosiban versus placebo in the treatment of threatened preterm birth between 30 and 34 weeks gestation: Study protocol of the 4-year APOSTEL 8 follow-up
van der Windt, L., Klumper, J., van Limburg Stirum, E. V. J., van 't Hooft, J., van Wely, M., van Wassenaer-Leemhuis, A. G., Pajkrt, E., Oudijk, M. A., de Boer, M. A., van den Akker, E. S. A., Huisjes, A. J. M., Sikkema, J. M., Schaaf, J., Visser, H., Papatsonis, D. W. M., Zwart, J. J., van Laar, J. O. E. H., Baalman, J., Gordijn, K. S. J., van der Ham, D. P., & 12 others, 18 Jul 2024, In: BMJ Open. 14, 7, e083600.Research output: Contribution to journal › Article › Academic › peer-review
-
Pessary or progesterone to prevent preterm birth in women with short cervical length: protocol of the 4-6 year follow-up of a randomised controlled trial (Quadruple-P)
Quadruple-P study group, 24 Aug 2022, In: BMJ Open. 12, 8, p. e064049Research output: Contribution to journal › Article › Academic › peer-review
-
Long-term outcomes following antenatal exposure to low-dose aspirin: study protocol for the 4-year follow-up of the APRIL randomised controlled trial
Landman, A. J. E. M. C., van Limburg Stirum, E. V. J., van 't Hooft, J., Leemhuis, A. G., Finken, M. J. J., van Baar, A. L., Roseboom, T. J., Ravelli, A. C. J., van Wely, M., Oosterlaan, J., Painter, R. C., Pajkrt, E., Oudijk, M. A. & de Boer, M. A., 1 Aug 2022, In: BMJ Open. 12, 8, p. e060632 e060632.Research output: Contribution to journal › Article › Academic › peer-review
- All publications